Life Sciences Insights from Industry

RSS

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the life sciences industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.

Milestones in microCT development: an interview with Alexander Sasov, CEO, Bruker MicroCT

MicroCT (micron-scale computed tomography) technology was completely unknown when it began to be commercially available more than 15 years ago....

From Bruker BioSpin - NMR, EPR and Imaging 2 Mar 2015

Liquid Nitrogen generation: an interview with Andy Boyle, COO, MMR Technologies, Inc

Liquid Nitrogen has many uses and applications beyond that of the medical and life sciences. In addition to dermatological use, biological specimen and embryo preservation, our customers use the Elan2 for cooling the outer jackets of MRI systems, semiconductor radiation detector cooling, infrared detector cooling and cryogenic annealing of metals.

From MMR Technologies 11 Feb 2015

Magnetizing biomolecules: an interview with Dr. Fred Whipple, AMSBIO

Nanoparticle technology was originally developed in the 1980s and 1990s. As the technology evolved, it soon became possible to produce uniform nanoscopic beads that are magnetic, and that also have a variety of specific surface chemistries. It was immediately evident that such beads could be used to great advantage for biochemical separations.

From AMS Biotechnology 10 Feb 2015

Productive Pipetting - are robots the only solution? An interview with Juerg Bass, Integra Biosciences

Traditional manual pipettes are easy to operate, very affordable but limited regarding throughput. Laboratory robots offer fast, automated pipetting but require time to program, set up and come at a much higher price tag.

From INTEGRA Biosciences 3 Feb 2015

CRISPR/Cas9 genome editing: an interview with Maja Petkovic

RNA guided CRISPR nucleases have a great potential for genome modification in many different organisms.

From AMS Biotechnology 9 Dec 2014

Life science investment in Northern England: an interview with Dr Geoff Davison, CEO, Bionow

There are a number of challenges, but primarily, it's access to funding. The recent BioCap Conference focussed on the access small businesses have to funding and how that's driven by changes in the market place.

27 Oct 2014

Botanical dietary supplement screening with NMR and MS – an interview with Kim Colson

My name is Kim Colson. I’m the Business Development Manager for Bruker Biospin, and right now my group is focusing on the botanical and herbal products and dietary supplements industry, and bringing new tools to that industry that will help to meet their needs for quality control assurance.

From Bruker BioSpin - NMR, EPR and Imaging 1 Aug 2014

NMR spectroscopy for in-vitro diagnostic research: an interview with Dr. Manfred Spraul, Director of NMR Applications, Bruker BioSpin

Our aim is to open new fields to NMR where we haven’t been before. Because of the extreme stability of our instruments, we can now really think about new applications: going to hospitals, going to food companies and just placing an instrument there that works completely under automation.

From Bruker BioSpin - NMR, EPR and Imaging 2 Jul 2014

miRNA expression and inhibition: an interview with Maja Petkovic, AMSBIO

RNA interference is a process in which RNA molecules inhibit gene expression. This gene silencing process is controlled by RNA-induced silencing complex or RISC and is initiated by small duplex RNA molecules or miRNA that is present inside cell plasma.

From AMS Biotechnology 14 Apr 2014

3D cell culture: an interview with Dr. Elad Katz, Senior Scientist, AMSBIO

For over fifty years now, we have used 2D cell cultures to culture a variety of cells such as epithelial and blood cells and these are excellent for maintaining cells in their inherent state, under controlled, temperature and other conditions. However, they are limited in preserving the genotype and the phenotype of the original tissue these cells came from.

From AMS Biotechnology 31 Mar 2014

Nanomedicine – past, present and future: an interview with Frank Boehm, CEO NanoApps Medical Inc.

The fundamental discipline of nanotechnology is poised to change virtually every aspect of our lives, in just about any sector we can think of.

4 Mar 2014

Nanoparticle analysis: an interview with Bernardo Cordovez, CEO of Optofluidics

Nanoparticle analysis is a very important field. Basically, we live in a world that is immersed in nanoparticles. From the paint we use, to the processes that go on within our very own bodies, nanoparticles play a role and because there are so many nanoparticles everywhere, they need to be analyzed for a variety of reasons.

From Halo Labs 24 Feb 2014

The future of DNA sequencing: an interview with Barrett Bready, CEO of Nabsys

The first methods for sequencing DNA were developed in the late 1970s. Frederick Sanger developed rapid DNA sequencing methods and published a method for "DNA sequencing with chain-terminating inhibitors,” while Walter Gilbert and Allan Maxam developed "DNA sequencing by chemical degradation". Both methods quickly gained strong followings and were used to sequence a wide variety of DNAs.

18 Feb 2014

Microplate readers: an interview with Ville Haaslahti, Managing Director, Hidex

The Hidex Sense is a new microplate reader which combines several different detection technologies. Such instruments have been available for quite some time already. What the Hidex Sense brings is really clearly defined in a few words: Every assay, effortless operation, performance beyond comparison, simply at your fingertip.

From Hidex 21 Nov 2013

Biomedical testing: an interview with Ed Moriarty, General Manager of the ElectroForce Systems Group of Bose Corporation

Bose has been committed to electromagnetic technology and research since its founding close to 50 years ago. In the audio field, it’s well known that reproducing sound with lifelike detail requires extraordinary control of a loudspeaker’s motion.

From TA Instruments 4 Nov 2013

Serialization: an interview with Dr. Sue Miles, UK Site Director at PCI - Packaging Coordinators Inc.

Pharmaceutical Serialization is a process whereby every saleable pack of drug product will have a unique Serial Code related to its Global Trade Identification Number (GTIN). The packaging of drugs will need to change to enable the inclusion of (typically) a 2D Matrix barcode and 4 elements of human readable text in replacement of the current Lot & Expiry. Although these two codes are still present, they are most commonly joined by the product GTIN and its serial number.

From Packaging Coordinators Inc. (PCI) 17 Sep 2013

Secure sample storage in Biobanking: an interview with Mr Jacko Duker, Procesmanager at the LifeLines Project

The Lifelines Project was started in 2006 as a large-scale genetic study into the mechanisms behind healthy aging. In this interview Procesmanager Jacko Duker tells us about the scale and impact of the project, and how Panasonic ULT freezers have provided a solution for keeping their irreplaceable samples safe.

From Panasonic Biomedical 12 Sep 2013

Bioscience development: an interview with Dr E. Neil Lewis, Chief Technology Officer, Malvern Instruments

While there is still large-scale investment in traditional small molecule pharmaceuticals, the past decade has seen a major shift towards the development of biological molecules for therapeutic purposes.

From Malvern Panalytical 11 Sep 2013

New uses for old drugs: an interview with Kate Hudson-Farmer, PhD MBA, Senior Consultant, Cambridge Consultants

Many older drugs are well understood from a safety perspective and have often been used successfully off label for other indications.

From Clinigen Group plc 22 Aug 2013

Consumable selection: an interview with Rob Bunn, Marketing Program Manager EMEA at Agilent Technologies

There are five different ways. The first one is the simplest: they just go with what they already know. It’s the tried and tested methods. They’ll buy from the same suppliers they’ve already bought from, and, if they want to tweak it slightly, then they’ll probably go to them first. It’s just using what they already have.

From Agilent Technologies - Consumables 13 Aug 2013